Cutler Group LP Synlogic, Inc. Call Options Transaction History

Cutler Group LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Jul 19, 2021	SELL	$3.0 - $4.39 $300 - $438	-100 Reduced 50.0%	100 $0
Q1 2021 Apr 26, 2021	SELL	$2.2 - $5.05 $1,760 - $4,040	-800 Reduced 80.0%	200 $0
Q1 2020 May 07, 2020	BUY	$1.39 - $3.19 $1,390 - $3,190	1,000 New	1,000 $0

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.